Ipca Laboratories Limited (NSE: IPCALAB)
India
· Delayed Price · Currency is INR 1,573.55
-0.95 (-0.06%)
Nov 21, 2024, 3:30 PM IST
Ipca Laboratories Revenue
Ipca Laboratories had revenue of 23.81B INR in the quarter ending September 30, 2024, with 17.07% growth. This brings the company's revenue in the last twelve months to 84.98B, up 27.20% year-over-year. In the fiscal year ending March 31, 2024, Ipca Laboratories had annual revenue of 77.06B with 23.33% growth.
Revenue (ttm)
84.98B
Revenue Growth
+27.20%
P/S Ratio
4.68
Revenue / Employee
4.92M
Employees
17,335
Market Cap
399.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 77.06B | 14.58B | 23.33% |
| Mar 31, 2023 | 62.48B | 4.18B | 7.16% |
| Mar 31, 2022 | 58.31B | 4.10B | 7.56% |
| Mar 31, 2021 | 54.21B | 7.71B | 16.58% |
| Mar 31, 2020 | 46.50B | 8.75B | 23.18% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIpca Laboratories News
- 6 weeks ago - Pharma stocks update: IPCA Labs up 3.27%, JB Chem 3.18%, Glenmark 2.90%, Torrent Pharma 2.43%, Divis Labs 2.51% - Business Upturn
- 2 months ago - Nomura expects IPCA Labs shares to rally over 20% from current price, retains Buy call - Business Upturn